FDG-PET in pediatric posterior fossa brain tumors.

Published

Journal Article

Seventeen pediatric patients with posterior fossa brain tumors were studied with 2-[18F]fluoro-2-deoxy-D-glucose (FDG) and positron emission tomography (PET). The FDG uptake was ranked by two observers, and the results were correlated with tumor histology. Increased FDG uptake was associated with more malignant and aggressive tumor types. Heterogeneity of FDG uptake was associated with previous therapy, including radiation therapy and chemotherapy. 2-[18F]Fluoro-2-deoxy-D-glucose PET will likely be an important adjunct in the management of pediatric posterior fossa tumors, much as in adult patients with brain tumors.

Full Text

Duke Authors

Cited Authors

  • Hoffman, JM; Hanson, MW; Friedman, HS; Hockenberger, BM; Oakes, WJ; Halperin, EC; Coleman, RE

Published Date

  • January 1, 1992

Published In

Volume / Issue

  • 16 / 1

Start / End Page

  • 62 - 68

PubMed ID

  • 1729308

Pubmed Central ID

  • 1729308

International Standard Serial Number (ISSN)

  • 0363-8715

Digital Object Identifier (DOI)

  • 10.1097/00004728-199201000-00011

Language

  • eng

Conference Location

  • United States